nach oben

Abdominal Radiology

Erschienen in:

19.01.2024 | Interventional Radiology

Image-guided percutaneous ablation of hepatic epithelioid hemangioendothelioma

verfasst von: Emmy Y. Hu, Sharath K. Bhagavatula, Andy Shi, Priscilla Merriam, Vincent M. Levesque, Paul B. Shyn

Erschienen in: Abdominal Radiology | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Disease control and survival following percutaneous ablation of hepatic epithelioid hemangioendothelioma (EHE) was studied retrospectively.

Methods

Six patients underwent 16 image-guided ablation procedures to treat 35 liver tumors from 2015 to 2022 (17 microwave ablation, 9 irreversible electroporation, 8 cryoablation, and 1 radiofrequency ablation). Technical success, local progression, intrahepatic progression, distant progression, overall survival, and adverse events were assessed.

Results

Four of six (67%) patients were treatment naïve prior to ablation. The mean length of imaging follow-up from first ablation procedure was 43.0 ± 31.2 months. Thirty-three of 35 (94.3%) ablated tumors did not progress locally. Three of 6 patients (50%) had new intrahepatic progression and underwent repeat ablation or systemic treatment. No extrahepatic progression was observed. One patient died from EHE 2.7 years after initial diagnosis. No severe adverse events occurred.

Conclusion

Percutaneous ablation is feasible, often in a staged fashion, and may provide favorable intermediate to long-term disease control for patients with hepatic EHE.

Graphical abstract

Kou K, Chen Y-G, Zhou J-P, Sun X-D, Sun D-W, Li S-X, Lv G-Y (2020) Hepatic epithelioid hemangioendothelioma: Update on diagnosis and therapy. World J Clin Cases 8:3978–3987. https://doi.org/10.12998/wjcc.v8.i18.3978

Cao L, Hong J, Zhou L, Ye Y, Liu Y, Yu J, Zheng S (2019) Selection of treatment for hepatic epithelioid hemangioendothelioma: a single-center experience. World J Surg Oncol 17:183. https://doi.org/10.1186/s12957-019-1729-yCrossRefPubMedPubMedCentral

Cardinal J, de Vera ME, Marsh JW, Steel JL, Geller DA, Fontes P, Nalesnik M, Gamblin TC (2009) Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 cases. Arch Surg 144:1035–1039. https://doi.org/10.1001/archsurg.2009.121CrossRefPubMed

Liu X-L, Yang Z-Y (2021) Outcomes of hepatic epithelioid hemangioendothelioma with different managements: a retrospective investigation. Eur Rev Med Pharmacol Sci 25:4274–4282. https://doi.org/10.26355/eurrev_202106_26133

S S, Ab M, Am F, C M, C M, A C, Cr A, J B, E B, S B, R B, S B, Jy B, S B, I B, Jvmg B, K B, T B, D C, E DA, M D-S, A D, M E, C E, A F, V F, A F, Cdm F, X GDM, H G, Ra G, F G, G G, J G, R H, N H, P H, P H, H J, Rl J, C J, B K, A K, A LC, F LG, A L, H L, A LP, J MB, O M, P M, R M, O M, M M, M M, G O, E P, Ma P, S P, S P-N, Cp R, V R, Ara R, P R, Bp R, P R, Aa S, C S, G S, M S, S S, P S, D S, Sj S, K SH, Wd T, A T, A T, Wta van der G, Maj VDS, W VH, G van O, Aj W, M W, J W, N Z, C Z, Pg C, Ap DT, A G (2021) Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts. ESMO open 6:. https://doi.org/10.1016/j.esmoop.2021.100170

Mehrabi A, Kashfi A, Fonouni H, Schemmer P, Schmied BM, Hallscheidt P, Schirmacher P, Weitz J, Friess H, Buchler MW, Schmidt J (2006) Primary malignant hepatic epithelioid hemangioendothelioma. Cancer 107:2108–2121. https://doi.org/10.1002/cncr.22225CrossRefPubMed

Tong D, Constantinidou A, Engelmann B, Chamberlain F, Thway K, Fisher C, Hayes A, Fotiadis N, Messiou C, Miah AB, Zaidi SH, Benson C, Graaf WVD, Jones RL (2019) The Role of Local Therapy in Multi-focal Epithelioid Haemangioendothelioma. Anticancer Research 39:4891–4896. https://doi.org/10.21873/anticanres.13675

Kaltenmeier C, Stacchiotti S, Gronchi A, Sapisochin G, Liu H, Ashwat E, Gunabushanam V, Reddy D, Thompson A, Geller D, Tohme S, Zureikat A, Molinari M (2022) Treatment modalities and long-term outcomes of hepatic hemangioendothelioma in the United States. HPB 24:1688–1696. https://doi.org/10.1016/j.hpb.2022.03.013CrossRefPubMed

Kamarajah SK, Robinson D, Littler P, White SA (2018) Small, incidental hepatic epithelioid haemangioendothelioma the role of ablative therapy in borderline patients. J Surg Case Rep 2018:rjy223. https://doi.org/10.1093/jscr/rjy223

10.

Neal RE, Kavnoudias H, Cheung W, Golebiowski B, McLean CA, Thomson KR (2013) Hepatic epithelioid hemangioendothelioma treated with irreversible electroporation and antibiotics. J Clin Oncol 31:e422-426. https://doi.org/10.1200/JCO.2012.44.9736CrossRefPubMed

11.

Thomson KR, Cheung W, Ellis SJ, Federman D, Kavnoudias H, Loader-Oliver D, Roberts S, Evans P, Ball C, Haydon A (2011) Investigation of the Safety of Irreversible Electroporation in Humans. Journal of Vascular and Interventional Radiology 22:611–621. https://doi.org/10.1016/j.jvir.2010.12.014CrossRefPubMed

12.

Khalilzadeh O, Baerlocher MO, Shyn PB, Connolly BL, Devane AM, Morris CS, Cohen AM, Midia M, Thornton RH, Gross K, Caplin DM, Aeron G, Misra S, Patel NH, Walker TG, Martinez-Salazar G, Silberzweig JE, Nikolic B (2017) Proposal of a New Adverse Event Classification by the Society of Interventional Radiology Standards of Practice Committee. Journal of Vascular and Interventional Radiology 28:1432-1437.e3. https://doi.org/10.1016/j.jvir.2017.06.019CrossRefPubMed

13.

Wang L-R, Zhou J-M, Zhao Y-M, He H-W, Chai Z-T, Wang M, Ji Y, Chen Y, Liu C, Sun H-C, Wu W-Z, Ye Q-H, Zhou J, Fan J, Tang Z-Y, Wang L (2012) Clinical experience with primary hepatic epithelioid hemangioendothelioma: retrospective study of 33 patients. World J Surg 36:2677–2683. https://doi.org/10.1007/s00268-012-1714-xCrossRefPubMed

14.

Merriam P, Nathenson MJ (2021) Liver transplantation for hepatic epithelioid hemangioendothelioma. Cancer 127:3714–3716. https://doi.org/10.1002/cncr.33751CrossRefPubMed

15.

Grotz TE, Nagorney D, Donohue J, Que F, Kendrick M, Farnell M, Harmsen S, Mulligan D, Nguyen J, Rosen C, Reid-Lombardo KM (2010) Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option? HPB (Oxford) 12:546–553. https://doi.org/10.1111/j.1477-2574.2010.00213.xCrossRefPubMed

Titel: Image-guided percutaneous ablation of hepatic epithelioid hemangioendothelioma
verfasst von: Emmy Y. Hu
Sharath K. Bhagavatula
Andy Shi
Priscilla Merriam
Vincent M. Levesque
Paul B. Shyn
Publikationsdatum: 19.01.2024
Verlag: Springer US
Erschienen in: Abdominal Radiology / Ausgabe 4/2024
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-023-04154-y

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Image-guided percutaneous ablation of hepatic epithelioid hemangioendothelioma